...
首页> 外文期刊>Journal of Structural Biology >NMR structure of CmPI-II, a non-classical Kazal protease inhibitor: Understanding its conformational dynamics and subtilisin A inhibition
【24h】

NMR structure of CmPI-II, a non-classical Kazal protease inhibitor: Understanding its conformational dynamics and subtilisin A inhibition

机译:CMPI-II的NMR结构,非古典kazal蛋白酶抑制剂:了解其构象动态和枯草杆菌蛋白酶抑制

获取原文
获取原文并翻译 | 示例
           

摘要

Subtilisin-like proteases play crucial roles in host-pathogen interactions. Thus, protease inhibitors constitute important tools in the regulation of this interaction. CmPI-II is a Kazal proteinase inhibitor isolated from Cenchritis muricatus that inhibits subtilisin A, trypsin and elastases. Based on sequence analysis it defines a new group of non-classical Kazal inhibitors. Lacking solved 3D structures from this group prevents the straightforward structural comparison with other Kazal inhibitors. The 3D structure of CmPI-II, solved in this work using NMR techniques, shows the typical fold of Kazal inhibitors, but has significant differences in its N-terminal moiety, the disposition of the CysI-CysV disulfide bond and the reactive site loop (RSL) conformation. The high flexibility of its N-terminal region, the RSL, and the alpha-helix observed in NMR experiments and molecular dynamics simulations, suggest a coupled motion of these regions that could explain CmPI-II broad specificity. The 3D structure of the CmPI-II/subtilisin A complex, obtained by modeling, allows understanding of the energetic basis of the subtilisin A inhibition. The residues at the P2 and P2' positions of the inhibitor RSL were predicted to be major contributors to the binding free energy of the complex, rather than those at the P1 position. Site directed mutagenesis experiments confirmed the Trp14 (P2') contribution to CmPI-II/subtilisin A complex formation. Overall, this work provides the structural determinants for the subtilisin A inhibition by CmPI-II and allows the designing of more specific and potent molecules. In addition, the 3D structure obtained supports the existence of a new group in non-classical Kazal inhibitors.
机译:枯草杆菌蛋白酶样蛋白酶在宿主病原体相互作用中起着至关重要的作用。因此,蛋白酶抑制剂构成了该相互作用调节的重要工具。 CMPI-II是抑制枯草芽孢子A,胰蛋白酶和弹性酶的Cenchtolis Muricatus分离的Kazal蛋白酶抑制剂。基于序列分析,它定义了一组新的非古典kazal抑制剂。缺乏来自该组的解决3D结构防止与其他kazal抑制剂的直接结构比较。使用NMR技术在这项工作中解决了CMPI-II的3D结构,显示了Kazal抑制剂的典型折叠,但其N-末端部分具有显着差异,Cysi-Cysv二硫键和反应性部位环的布置( RSL)构象。在NMR实验和分子动力学模拟中观察到的N末端区域,RSL和α-螺旋的高柔韧性,提出了可以解释CMPI-II广泛特异性的这些区域的耦合运动。 CMPI-II /枯草杆菌蛋白酶的3D结构是通过建模获得的复合物,允许了解枯草杆菌蛋白酶的能量基础抑制。预计抑制剂RSL的P2和P2'位置的残基是对复合物的粘合性的主要贡献者,而不是P1位置的主要贡献者。网站定向诱变实验证实了TRP14(P2')对CMPI-II /枯草杆菌蛋白酶的贡献是复杂的形成。总体而言,这项工作为枯草杆菌蛋白酶提供了CMPI-II的抑制作用的结构决定因素,并允许设计更具体和有效的分子。此外,所获得的3D结构支持非古典kazal抑制剂中的新组的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号